Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

Four symptoms not to ignore if you’ve had cancer

January 23, 2018 | Denise Heady

Neurosurgeon and scientist Rahul Jandial says some symptoms should never be ignored by former cancer patients. More and more people are surviving cancer, thanks to advanced cancer treatments and screening tools.

Cancer insights: Cancer patients are superhuman

June 5, 2017 | Rahul Jandial, M.D., Ph.D.

In the past seven years at City of Hope, I’ve had the privilege of providing care for many patients with cancer. Quite simply, they are the real superhumans. Please allow me to offer four examples for your consideration, from my personal insight.

Wolf in sheep's clothing: breast cancer cloaks itself in brain proteins to invade the brain

March 14, 2017 | Denise Heady

More women than ever are surviving breast cancer only to die of secondary brain tumors years after they’ve been declared cancer-free. This is particularly true for patients with the breast cancer subtype HER2-positive. Now City of Hope researchers have discovered how this happens.

Neurosurgeon receives Breakthrough Award for study of brain metastases

July 20, 2015 | Denise Heady

Rahul Jandial, assistant professor in the Division of Neurosurgery at City of Hope, received the Department of Defense Breakthrough Award, which will support his research to further understand why women with HER2-positive breast cancer have higher rates of brain metastases.

June Grad Student Forum: Cecilia Choy

July 9, 2014 | Cecilia Choy

Cooperation of Neurotrophin Receptor TrkB and Her2 in Breast Cancer Cells Facilitates Brain Metastasis Cecilia Choy, Josh Neman, Matthew Duenas, Hubert Li, Nagarajan Vaidehi, Rahul Jandial Metastases are responsible for 90% of all cancer deaths, and patients diagnosed with brain metastasis have a dismal 20% probability of one-year survival.